Recce Pharmaceuticals Ltd (ASX:RCE) Share Price and News

Market Cap (1-Jul) $89,395,320 (718th)	Close (30-Jun) $0.63 0 (0%)	Volume (30-Jun) 55,179	Shortsold (19-Jun) 190,561 (0.07%) (455th)
52w High $0.57	52w Low $0.275	P/E -	EPS -0.09

	Subject
	RCE RCE Ann: Ethics Approval for Phase I/II UTI Trial Expansion
	1 (current) 2 3
	RCE RCE Ann: Change of Director's Interest Notice - J Graham
	RCE RCE Ann: DFI Clinical Trial Outpatient Nurses Appointed
	RCE RCE Ann: WA Government Sponsorship for BIO Korea 2023
	RCE RCE Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	RCE RCE Ann: Ethics Approval to Start Phase I/II (I.V.) Clinical Trial
	RCE RCE Ann: RECCE Trademark Registered - Israel
	RCE RCE Ann: New Family 4 Patent to be Granted for RECCE Anti-Infectives
	RCE RCE Ann: Recce Receives Further A$973,144 R&D Advance
	RCE RCE Ann: Corporate Presentation - WI Emergence 2023
	RCE RCE Ann: Appendix 4D and Interim Financial Report
	RCE RCE Ann: Investor Presentation - Spark Plus Biotech Day
	RCE RCE Ann: Recce Selects CMAX for Phase I/II UTI Clinical Trial
	RCE RCE Ann: Cleansing Statement
	RCE RCE Ann: Application for quotation of securities - RCE
	RCE RCE Ann: RECCE Trademark Registered - Hong Kong
	RCE RCE Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	RCE RCE Ann: A$6.21m Received from R&D Rebate Payments
	RCE RCE Ann: Cleansing Statement
	RCE RCE Ann: Application for quotation of securities - RCE
	RCE RCE Ann: JP Morgan Healthcare Conference
	RCE RCE Ann: Australian Patent to be Granted for RECCE Anti-Infectives
	RCE RCE Ann: Anti-Infective Research Unit est. at Murdoch Children's
	RCE RCE Ann: Approval to Start Phase I/II Diabetic Foot Ulcer Study
	RCE RCE Ann: Trading Halt
	RCE RCE Ann: Pause in Trading
	RCE RCE Ann: Change of Director's Interest Notice - A McKeough
	RCE RCE Ann: Notification regarding unquoted securities - RCE
	RCE RCE Ann: Constitution
	RCE RCE Ann: Results of Meeting
	RCE RCE Ann: AGM Presentation
	RCE RCE Ann: Investor Presentation - Spark Plus Healthcare Day
	RCE RCE Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	RCE RCE Ann: Anti-Infective Portfolio Update and Webinar details
	RCE RCE Ann: Pause in Trading
	RCE RCE Ann: R327 COVID Study Update
	RCE RCE Ann: Pause in trading
	RCE RCE Ann: Notice of Annual General Meeting/Proxy Form
	RCE RCE Ann: Expansion and Acceleration of Clinical Programs
	RCE RCE Ann: 2022 Annual General Meeting
	RCE RCE Ann: Cleansing Statement
	RCE RCE Ann: Application for quotation of securities - RCE
	RCE RCE Ann: Recce Delivers Opening R&D Address at World AMR Congress
	RCE RCE Ann: RCE Appoints Dr John Prendergast as Executive Chairman
	RCE RCE Ann: Initial Director's Interest Notice - A McKeough
	RCE RCE Ann: Recce Appoints Alistair McKeough to Board of Directors
	RCE RCE Ann: Appendix 4G
	RCE RCE Ann: Annual Report to shareholders
	RCE RCE Ann: Appendix 4E
	RCE RCE Ann: Cleansing Statement

Similar Companies

Cann Group

CAN

Creso Pharma

CPH

Ecofibre

EOF

Incannex Healthcare

IHL

Medical Developments International

MVP

Mayne Pharma Group

MYX

Neuren Pharmaceuticals

NEU

Probiotec

PBP

Starpharma Holdings

SPL

End of Day Prices

Date	Close	Volume	Change
30-Jun	$0.29	556,441	-0.02 (6.45%)
27-Jun	$0.31	82,292	+0.01 (3.33%)
26-Jun	$0.30	101,281	+0.01 (3.45%)
24-Jun	$0.29	127,792	-0.01 (1.69%)
23-Jun	$0.30	133,150	-0.01 (1.67%)
20-Jun	$0.30	127,651	+0.01 (1.69%)
19-Jun	$0.30	172,965	-0.01 (3.28%)
18-Jun	$0.31	174,328	0.00 (0.00%)
16-Jun	$0.31	82,188	-0.01 (3.17%)
13-Jun	$0.32	164,503	-0.02 (5.97%)
12-Jun	$0.34	114,757	+0.03 (9.84%)
06-Jun	$0.31	532,258	-0.02 (4.69%)
05-Jun	$0.32	161,800	0.00 (0.00%)
04-Jun	$0.32	208,143	-0.01 (1.54%)
03-Jun	$0.33	507,297	-0.02 (5.80%)
4 up, 9 down, and 2 flat days

High $0.63	Low $0.59	Trades 32	Turnover $33,720	Volume 55,179
30 June 2023 at 4:10pm

High $0.63	Low $0.59	Trades 32	Turnover $33,720	Volume 55,179
30 June 2023 at 4:10pm

Recce Pharmaceuticals Ltd Health Care
Blood Pharmaceuticals

$0.625 0.005 (0.81%)

$0.625 0.005 (0.81%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Recce Pharmaceuticals Ltd Health Care Blood Pharmaceuticals

$0.625 0.005 (0.81%)

$0.625 0.005 (0.81%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Recce Pharmaceuticals Ltd Health Care
Blood Pharmaceuticals